Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Fatal liver injury associated with clopidogrel
Fundamental and Clinical Pharmacology, Volume 24, No. 4, Year 2010
Notification
URL copied to clipboard!
Description
Clopidogrel, an adenosine diphosphate receptor blocker, is widely used as an adjunctive antiplatelet therapy in acute coronary syndrome and percutaneous coronary stenting. It appears to be a safe drug with few occurrences of liver side-effects that usually resolved after drug withdrawal. We report a serious liver injury with fatal outcome in a 63-year-old man developed 19 days after starting clopidogrel for percutaneous coronary stenting. © 2009 Société Française de Pharmacologie et de Thérapeutique.
Authors & Co-Authors
Kastalli, Sarrah
Tunisia, Tunis
Centre National de Pharmacovigilance
El Aïdli, Sihem
Tunisia, Tunis
Centre National de Pharmacovigilance
Zaïem, Ahmed
Tunisia, Tunis
Centre National de Pharmacovigilance
Ben Abdallah, Hatem
Tunisia, Tunis
Université de Tunis el Manar, Hôpital Militaire de Tunis
Daghfous, Riadh
Tunisia, Tunis
Centre National de Pharmacovigilance
Statistics
Citations: 16
Authors: 5
Affiliations: 2
Identifiers
Doi:
10.1111/j.1472-8206.2009.00791.x
ISSN:
07673981
e-ISSN:
14728206
Research Areas
Violence And Injury